Anti-Epstein-Barr Virus (EBV-EA-R) Antibody

This Mouse-derived monoclonal antibody from Antibodies.com targets the Epstein-Barr Virus Early Antigen Restricted (EBV-EA-R) protein, a marker expressed during the lytic phase of EBV replication. Produced as a purified IgG1(k) preparation in unconjugated format, the antibody is supplied at 100 µg per vial and is validated for ELISA, Western blot, and IFA workflows.

EBV-EA-R serology helps detect acute infection or viral reactivation, distinguishing active disease from past exposure. Researchers studying EBV-associated malignancies, including nasopharyngeal carcinoma and certain lymphomas, use EA-R-specific reagents to characterize viral gene expression in infected cell lines and patient samples. The unconjugated format allows flexible pairing with custom reporter labels, supporting chromogenic and fluorescence-based detection in immunohistochemistry and immunofluorescence applications.